These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6273277)

  • 1. Heterogeneous forms of thyroid-stimulating hormone in mouse thyrotropic tumor and serum: differences in receptor-binding and adenylate cyclase-stimulating activity.
    Pekonen F; Carayon P; Amr S; Weintraub BD
    Horm Metab Res; 1981 Nov; 13(11):617-20. PubMed ID: 6273277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished binding of thyroid-stimulating hormone in a transplantable rat thyroid tumor as a possible cause of hormone unresponsiveness.
    Mandato E; Meldolesi MF; Macchia V
    Cancer Res; 1975 Nov; 35(11 Pt 1):3089-93. PubMed ID: 171062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
    Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN
    Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraction and characterization of a thyrotropic material from the human placenta.
    Hershman JM; Starnes WR
    J Clin Invest; 1969 May; 48(5):923-9. PubMed ID: 5813651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms.
    Clark OH; Gerend PL; Cote TC; Nissenson RA
    Surgery; 1981 Aug; 90(2):252-61. PubMed ID: 6266060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and properties of an Indian major carp (Cirrhinus mrigala, Ham.) pituitary thyrotropin.
    Bandyopadhyay S; Bhattacharya S
    Gen Comp Endocrinol; 1993 May; 90(2):192-204. PubMed ID: 8319876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring forms of thyrotropin with low bioactivity and altered carbohydrate content act as competitive antagonists to more bioactive forms.
    Joshi LR; Weintraub BD
    Endocrinology; 1983 Dec; 113(6):2145-54. PubMed ID: 6641628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma.
    Abe Y; Ichikawa Y; Muraki T; Ito K; Homma M
    J Clin Endocrinol Metab; 1981 Jan; 52(1):23-8. PubMed ID: 6256403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
    Clark OH; Gerend PL
    Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-specific activity of heteromeric thyrotropin (TSH) analogs: development of synthetic TSH antagonists.
    Sheehan MT; Morbeck DE; Bergert ER; McCormick DJ; Milius RP; Morris JC
    Pept Res; 1995; 8(5):264-71. PubMed ID: 8589548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased high-molecular-weight thyrotropin with impaired biologic activity in a euthyroid man.
    Spitz IM; Le Roith D; Hirsch H; Carayon P; Pekonen F; Liel Y; Sobel R; Chorer Z; Weintraub B
    N Engl J Med; 1981 Jan; 304(5):278-82. PubMed ID: 6255331
    [No Abstract]   [Full Text] [Related]  

  • 12. Salmon thyroid-stimulating hormone: isolation, characterization, and development of a radioimmunoassay.
    Moriyama S; Swanson P; Larsen DA; Miwa S; Kawauchi H; Dickhoff WW
    Gen Comp Endocrinol; 1997 Dec; 108(3):457-71. PubMed ID: 9405122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyphloretin phosphate, an antagonist of thyrotropin action: evidence for an interaction with the hormone rather than the receptor.
    Amir SM; Kasagi K; Corretti M; Blank M; Ingbar SH
    Endocrinology; 1985 Sep; 117(3):860-8. PubMed ID: 2990874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sialic acid on adenylate cyclase activity and thyrotropin-receptor binding in human thyroid membranes.
    Adler GM
    Acta Biochim Pol; 1978; 25(4):343-7. PubMed ID: 220831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms.
    Clark OH; Gerend PL
    J Clin Endocrinol Metab; 1985 Oct; 61(4):773-8. PubMed ID: 2993348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antiidiotypic antibodies interact with the 93 kilodalton thyrotropin receptor and exhibit heterogeneous biological activities.
    Costagliola S; Ruf J; Durand-Gorde MJ; Carayon P
    Endocrinology; 1991 Mar; 128(3):1555-62. PubMed ID: 1999172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilized TSH-receptor: its usefulness for the radioligand receptor assay for TSH and TSH-displacing antibody.
    Kotulla P; Schleusener H
    J Endocrinol Invest; 1981; 4(2):155-60. PubMed ID: 6268690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioligand receptor assay for TSH and TSH-binding-inhibiting antibodies using solubilized TSH-receptor.
    Kotulla P; Kostner C; Schleusener H
    J Endocrinol Invest; 1983 Apr; 6(2):135-8. PubMed ID: 6134766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of radioiodinated thyrotropin into receptor active and inactive components by column chromatography.
    Powell-Jones CH; McQuade RD; Thomas CG; Nayfeh SN
    Mol Cell Endocrinol; 1982; 28(3):275-87. PubMed ID: 6295838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.